Today: September 5, 2015, 6:21 pm
  

SADIF Analytics releases new rating update reports for Brazilian stocks

Summary - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

 

PR-Inside.com: 2014-08-25 13:32:04
Ilhavo, Portugal — SADIF Investment Analytics, announces a new rating update report covering the following companies:

Report Summary for: Cia Brasil. de Distrib. Pao de Acucar is an above average quality company with a positive outlook. Cia Brasil. de Distrib. Pao de Acucar has strong business growth and is run by passable management. The trend in Cia Brasil. de Distrib. Pao de Acucar fair value exchange rate against its closest rated-competitor, Cosan Limited, has been stable over the past 2 weeks. When compared to its closest competitor, Cia Brasil. de Distrib. Pao de Acucar shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.

Press Information
SADIF - Investment Analytics
SADIF - Investment Analytics
Rua Domingos F. Pinto Basto, 21
3830-176 Ilhavo, Portugal

António Mendes
Partner
(+351) 234 296930
email
sadifanalytics.com/

Published by
Antonio Mendes
(+351) 234 322 037
e-mail
www.sadifanalytics.com
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.